ArticlebioRxiv : the preprint server for biology2025
Development of a PEGylated Parylene Nanopocket Membrane for the Capture and Release of Lipid Vesicles.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Membranes are commonly used for the separation and purification of a variety of biological species. In this study, we developed a nanopocket membrane that can capture nanoparticles and extracellular vesicles in tangential flow filtration by pulling the species of interest into a nanopocket, while tangential flow washes away particles too large to be captured. We developed the pores using a four-step lithography process. By optimizing photolithography parameters, particularly exposure dose, we achieved well-defined pore shapes with the desired wall tilt, forming nanopocket geometries. We validated membrane performance using bead mixtures of varying diameters (50 nm-10 μm), demonstrating its ability to pass small particles, capture mid-sized particles, and exclude larger ones. Surface modification with poly(l-lysine)-grafted poly(ethylene glycol) enhanced this performance by reducing pore size and improving particle release. Additionally, we demonstrated selective capture and release of liposomes as well as EVs in the presence of fluorescently labeled BSA (f-BSA) protein. During this process, EVs were retained and later released, while f-BSA passed through, confirming selective capture and reduced protein contamination. These PEGylated nanopocket membranes constitute a low-pressure platform for gentle, size-selective isolation of nanoscale bioparticles, laying the groundwork for improved extracellular-vesicle analytics and point-of-care diagnostic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.